A61K 49/005
Characterised by the carrier molecule carrying the fluorescent agent
Official title: {characterised by the carrier molecule carrying the fluorescent agent}
A61K49/005 (Characterised by the carrier molecule carrying the fluorescent agent) appears on 1,859 US grants and 3,114 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,859
- Published applications
- 3,114
- Assignees
- 1,226
- Inventors
- 5,958
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 5 | 0 |
| 1995 | 9 | 0 |
| 1996 | 9 | 0 |
| 1997 | 13 | 0 |
| 1998 | 22 | 0 |
| 1999 | 15 | 0 |
| 2000 | 19 | 0 |
| 2001 | 27 | 8 |
| 2002 | 19 | 20 |
| 2003 | 11 | 39 |
| 2004 | 9 | 36 |
| 2005 | 13 | 48 |
| 2006 | 12 | 53 |
| 2007 | 18 | 64 |
| 2008 | 26 | 78 |
| 2009 | 20 | 90 |
| 2010 | 26 | 106 |
| 2011 | 45 | 124 |
| 2012 | 57 | 117 |
| 2013 | 69 | 143 |
| 2014 | 108 | 170 |
| 2015 | 91 | 161 |
| 2016 | 105 | 196 |
| 2017 | 148 | 188 |
| 2018 | 111 | 192 |
| 2019 | 149 | 186 |
| 2020 | 151 | 206 |
| 2021 | 110 | 176 |
| 2022 | 92 | 153 |
| 2023 | 98 | 150 |
| 2024 | 96 | 181 |
| 2025 | 82 | 133 |
| 2026 | 54 | 96 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Antibody conjugates and uses thereof6 Oct 2026US 12,753,242 B2GlycoNex Inc.
- Bimetallic fluorescent nanocomposites for cancer theranostics29 Sep 2026US 12,746,598 B2Council of Scientific and Industrial Research
- Antibodies targeting glioblastoma stem-like cells and methods of use thereof22 Sep 2026US 12,742,019 B2Wisconsin Alumni Research Foundation
- Anti-PD-1 antibodies1 Sep 2026US 12,723,079 B2PD-I Acquisition Group, LLC
- Compound, preparation method therefor, composition, kit and use thereof25 Aug 2026US 12,715,844 B2Signdo Biotechnology (Suzhou) Co., Ltd
- Fluorescein-labeled nerve targeting peptide formulations and related methods8 Oct 2026US 2026/0306676 A1Alume Biosciences, Inc.
- Method for detecting a gd2 positive cancer8 Oct 2026US 2026/0306677 A1Prinses Maxima Centrum Voor Kinderoncologie B.V.
- Method for Medical Imaging1 Oct 2026US 2026/0294251 A1Integro Theranositcs, LLC
- Antibodies targeting s100 proteins and uses thereof1 Oct 2026US 2026/0297172 A1Albert Einstein College of Medicine
- Anti-pd-l1 nanobody, preparation method therefor and use thereof1 Oct 2026US 2026/0297195 A1Kanglitai Biomedical (Qingdao) Co., Ltd.
Most cited
By later US patents
- Method and device for detecting and quantifying glucose in body fluids905US 5,342,789 ASensor Technologies, Inc. · 1994
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors891US 8,008,088 B2Masimo Laboratories, Inc. · 2011
- Non-invasive measurement of analytes836US 8,509,867 B2Cercacor Laboratories, Inc. · 2013
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors707US 8,029,765 B2Masimo Laboratories, Inc. · 2011
- SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors651US 8,466,286 B2Cercacor Laboratories, Inc. · 2013